Search filters

List of works by Prithviraj Bose

A phase 1/2 study of ruxolitinib and decitabine in patients with post-myeloproliferative neoplasm acute myeloid leukemia

scientific article published on 25 February 2020

A phase 2 study of pracinostat combined with ruxolitinib in patients with myelofibrosis

scientific article published on 11 January 2019

A phase 2 study of ruxolitinib in combination with azacitidine in patients with myelofibrosis

scientific article published on 05 September 2018

A phase II study of omacetaxine mepesuccinate for patients with higher-risk myelodysplastic syndrome and chronic myelomonocytic leukemia after failure of hypomethylating agents

scientific article published on 15 November 2018

A phase II trial of ruxolitinib in combination with azacytidine in myelodysplastic syndrome/myeloproliferative neoplasms.

scientific article

Advances in potential treatment options for myeloproliferative neoplasm associated myelofibrosis

scientific article published on 24 September 2019

Association of bone marrow fibrosis with inferior survival outcomes in chronic myelomonocytic leukemia.

scientific article published on 20 March 2018

Association of gene mutations with time-to-first treatment in 384 treatment-naive chronic lymphocytic leukaemia patients

scientific article published on 26 June 2019

Characteristics and outcomes of patients with therapy-related acute myeloid leukemia with normal karyotype

scientific article published on 04 May 2020

Clinical use of ruxolitinib in an academic medical center in unselected patients with myeloproliferative neoplasms not on clinical study

scientific article published on 5 August 2016

Clonal evolution and outcomes in myelofibrosis after ruxolitinib discontinuation

scientific article

Constitutive Phosphorylation of STAT3 by the CK2-BLNK-CD5 Complex

scientific article published on 27 January 2017

Early results of lower dose dasatinib (50 mg daily) as frontline therapy for newly diagnosed chronic-phase chronic myeloid leukemia.

scientific article

Emerging translational science discoveries, clonal approaches, and treatment trends in chronic myeloproliferative neoplasms

scientific article published on 20 June 2019

Givinostat: an emerging treatment for polycythemia vera

scientific article published on 21 July 2020

Haptoglobin is frequently low in patients with myelofibrosis: Clinical relevance

scientific article published on 8 March 2017

Hyper-CVAD plus nelarabine in newly diagnosed adult T-cell acute lymphoblastic leukemia and T-lymphoblastic lymphoma

scientific article

Ibrutinib dose and clinical outcome in chronic lymphocytic leukemia - learning from the 'real world'

scientific article published on 06 February 2019

Initial Report of a Phase I Study of LY2510924, Idarubicin, and Cytarabine in Relapsed/Refractory Acute Myeloid Leukemia ⬇️

JAK2 inhibitors for myeloproliferative neoplasms: what is next?

scientific article published on 12 May 2017

Janus kinase 2 variants associated with the transformation of myeloproliferative neoplasms into acute myeloid leukemia

scientific article published on 27 February 2019

Long-term follow-up of lower dose dasatinib (50 mg daily) as frontline therapy in newly diagnosed chronic-phase chronic myeloid leukemia

scientific article published on 25 September 2019

Management of myelofibrosis after ruxolitinib failure

scientific article published on 16 April 2020

Mixed myeloid chimerism and relapse of myelofibrosis after allogeneic stem cell transplantation

scientific article published on 11 July 2019

Mutational landscape of myelodysplastic/myeloproliferative neoplasm-unclassifiable

scientific article published on 21 September 2018

Novel Concepts of Treatment for Patients with Myelofibrosis and Related Neoplasms

scientific article published on 09 October 2020

Patients with post-essential thrombocythemia and post-polycythemia vera differ from patients with primary myelofibrosis

scientific article

Phase 1 study of belinostat (PXD-101) and bortezomib (Velcade, PS-341) in patients with relapsed or refractory acute leukemia and myelodysplastic syndrome

scientific article published on 28 December 2020

Phase II Trial of MEK Inhibitor Binimetinib (MEK162) in RAS-mutant Acute Myeloid Leukemia

scientific article published on 20 December 2018

Phase II trial of CPX-351 in patients with acute myeloid leukemia at high risk for induction mortality

scientific article published on 16 June 2020

Prognostic significance of baseline FLT3-ITD mutant allele level in acute myeloid leukemia treated with intensive chemotherapy with/without sorafenib

scientific article published on 24 June 2019

Prognostic value of blasts in peripheral blood in myelofibrosis in the ruxolitinib era

scientific article published on 22 July 2020

Routine sequencing in CLL has prognostic implications and provides new insight into pathogenesis and targeted treatments

scientific article published on 28 March 2019

Ruxolitinib for symptom control in patients with chronic lymphocytic leukaemia: a single-group, phase 2 trial

scientific article

STAT3-Induced Wnt5a Provides Chronic Lymphocytic Leukemia Cells with Survival Advantage

scientific article published on 23 October 2019

Significance of thrombocytopenia in patients with primary and postessential thrombocythemia/polycythemia vera myelofibrosis

scientific article

Sorafenib plus intensive chemotherapy improves survival in patients with newly diagnosed, FLT3-internal tandem duplication mutation-positive acute myeloid leukemia

scientific article published on 16 July 2019

T-PLL: another check on the venetoclax list?

scientific article published in December 2017

The early achievement of measurable residual disease negativity in the treatment of adults with Philadelphia-negative B-cell acute lymphoblastic leukemia is a strong predictor for survival

scientific article published on 19 November 2019

Treatment with a 5-day versus a 10-day schedule of decitabine in older patients with newly diagnosed acute myeloid leukaemia: a randomised phase 2 trial

scientific article published on 10 December 2018

Updates in the management of polycythemia vera and essential thrombocythemia

scientific article published on 30 August 2019

Venetoclax with Decitabine Versus Intensive Chemotherapy in Acute Myeloid Leukemia: A Propensity Score Matched Analysis Stratified by Risk of Treatment-related Mortality

scientific article published on 02 December 2020

Paulina is supported by:

About Paulina

Help